For about ten years, the case for using cannabis in post-traumatic stress disorder (PTSD) rested on one comparison. US military veterans (former soldiers) with PTSD were prescribed opioid painkillers at more than twice the rate of veterans with no mental health diagnosis. During those same years, doctors would not give them cannabis, a plant with fewer obvious harms. That comparison was true then and is still true. Then, in 2021, the first randomised trial tested whether cannabis itself treats PTSD. This article covers both findings and what they mean for you.
This article is not medical advice. PTSD has treatments with good evidence behind them. Do not read this article as a reason to avoid or delay them. If trauma symptoms are making your life hard, talk to a doctor or a mental health professional. You do not have to deal with it alone.
Translator’s note: In Thailand, cannabis flower is a controlled herb. It can be dispensed only with a PT 33 prescription (ภ.ท.33, the special cannabis prescription form) from an authorised practitioner. Section 9 explains the Thai rules in more detail.
1. Why researchers expected cannabis to help
PTSD is a disorder of fear memory. Something terrifying happened, and the body’s fear reaction was the right response at that moment. In PTSD, the reaction keeps firing long after the danger is gone.
The main symptoms come from this:
- intrusive memories that come back without warning;
- nightmares;
- hypervigilance (always being on guard and easily startled);
- avoidance of places, people and thoughts linked to the trauma.
Normally the brain learns to drop a fear once the danger stops coming back. Researchers call this fear extinction. The endocannabinoid system, the body’s own cannabinoid signalling system, is directly involved in this process.
The system’s main receptor in the brain is the CB1 receptor, the site where THC acts. CB1 receptors are densely packed in the amygdala, the small brain area that handles fear, and in the circuits connected to it.
This gave researchers a specific idea they could test. Cannabinoid signalling might help the brain unlearn fear. It might also make traumatic memories less upsetting, improve sleep and calm the constant alertness.
This is one of the better-built hypotheses in medical cannabis research. That is why the trial result in section 3 matters so much.
What you can do: when someone explains how cannabis “should” work for PTSD, ask which controlled trial tested it. An explanation of how a drug might work shows researchers what to test. It does not give you the result.
2. The 2012 opioid data, checked
The older argument for cannabis in PTSD was political, not clinical. Its factual core still holds.
In 2012 a US research team led by Seal published a study in JAMA (the Journal of the American Medical Association). They studied 141,029 US veterans of the wars in Iraq and Afghanistan who had a diagnosis related to pain. The team compared how often each group got opioids for pain.
| Group | Received opioids for pain |
|---|---|
| Veterans with PTSD | 17.8% |
| Veterans with another mental health diagnosis | 11.7% |
| Veterans with no mental health diagnosis | 6.5% |
The table below covers only veterans who were prescribed opioids. Those with PTSD showed the high-risk patterns more often than veterans with no mental health diagnosis.
| High-risk pattern | Veterans with PTSD | No mental health diagnosis |
|---|---|---|
| On high opioid doses | 23% | 16% |
| Also taking sedative-hypnotics (calming and sleeping medicines) | 41% | 8% |
| Getting refills early | 34% | 20% |
| On two or more opioids at once | 20% | 11% |
Serious harmful medical events happened to 10% of veterans who got opioids. Among veterans who did not get opioids, the figure was 4%.
So the older argument got the facts right. The reality may even have been worse than the argument said. The group least suited to opioids got them most often and at higher doses. They were also more often given sleeping medicines with them, and they had worse outcomes.
But showing that opioids are the wrong drug does not show that cannabis is the right one. Those are two separate claims, and the data above prove only the first. Advocacy treats them as one claim, and evidence keeps them apart.
What you can do: if you or a family member take opioid painkillers together with sleeping or calming pills, take the full list of medicines to the doctor. Ask for a review of the combination. In the 2012 data this combination was the most common high-risk pattern. The forum’s drug interactions list can help you prepare.
3. The first randomised trial (2021)
In 2021 a US research team led by Bonn-Miller published the first randomised controlled trial of whole-plant cannabis for PTSD in veterans. It appeared in PLOS ONE, an open-access science journal.
In a randomised controlled trial, each participant’s treatment is chosen by chance. That way the groups are alike at the start, and any difference at the end comes from the treatment. This trial was set up as follows.
Design
- Double-blind: neither the participants nor the researchers knew who got which product.
- Placebo-controlled: one product was a placebo, cannabis flower with almost no THC. It shows how much people improve without an active dose.
- Crossover, in two stages: participants took part in two stages and got a product in each. Results can then be compared within the same person.
- Size: 80 people enrolled and 76 finished stage 1.
The four products (all smoked cannabis flower)
| Product | THC | CBD |
|---|---|---|
| High-THC | about 12% | under 0.05% |
| High-CBD | 0.50% | 11% |
| THC and CBD combined | about 7.9% | 8.1% |
| Placebo | under 0.03% | — |
Participants smoked as much as they wanted (ad libitum), up to 1.8 g per day. Each stage lasted three weeks.
The route matters. The cannabis was smoked, so the result does not carry over directly to oils, capsules, edibles or vaporised products. Smoking also brings lung risks that the other routes do not. The forum topic on routes of administration explains how each route differs.
What was measured: the change in PTSD severity on the CAPS-5 (Clinician-Administered PTSD Scale). In this structured interview, a trained clinician scores each PTSD symptom.
Result
- Every group improved significantly, including the placebo group. Each person’s score after three weeks was clearly better than their own score at the start.
- None of the three active products did better than placebo.
- All three active products were generally well tolerated. Side effects were mild to moderate.
The research team’s own summary was this: all groups tolerated treatment well and improved significantly over three weeks. But no active product did statistically better than placebo in this short, preliminary trial.
What you can do: when you read a claim that cannabis helps PTSD, check three things. Was there a placebo group? How was the cannabis taken? How long did the study last? These answers show how much weight the claim can carry.
4. Everyone improved, including the placebo group: how to read that
This result leads to two conclusions, and they point in different directions.
It does not prove that cannabis is useless. Three weeks is short, and the trial was preliminary and fairly small. Because people smoked as much as they chose, the actual dose varied from person to person. A real effect too small for this trial to detect would give exactly this result.
It seriously weakens evidence from personal stories. People with PTSD took an inactive product inside a study, and they improved a lot. Anyone in the placebo group could honestly say, “I took something and got better.” On its own, a story about cannabis and PTSD looks the same as what this trial’s placebo group produced.
So one controlled trial counts for more than many personal reports, however sincere they are. Only a controlled design can tell a drug effect apart from the placebo effect. This trial looked for that difference and found none.
What you can do: before you repeat a cannabis-and-PTSD story in a post, on a farm visit or to a customer, remember that this trial’s placebo group would have told the same story. The topic on why personal testimony is not medical evidence explains what such stories are still useful for.
5. What the US veterans’ treatment guideline says, and why
In 2023 the US Department of Veterans Affairs and Department of Defense (VA/DoD) published a joint guideline. Its full name is the Clinical Practice Guideline for the Management of PTSD and Acute Stress Disorder. These two agencies care for a very large number of veterans with PTSD. They have every reason to want a treatment that works.
The guideline recommends against cannabis and cannabis-derived products for PTSD. It gives this a “strong against” rating. The reasons it gives are a lack of evidence that cannabis works, known side effects and related risks.
The guideline relied on this evidence:
- Systematic reviews (studies that collect and weigh all earlier research on a question) did not support cannabis for improving overall PTSD symptoms.
- The single randomised trial of whole-plant cannabis against placebo (section 3) found no significant difference in symptom reduction.
- Observational studies, which watch what people already do without assigning treatments, gave mixed and flawed results. One reported more improvement among cannabis users, but it was at high risk of bias. It recruited people who were already using cannabis for PTSD, so they tended to be people who already believed it helped. Another study found short-term relief while people were using cannabis, but no long-term change in PTSD symptoms.
The guideline also names four specific risks:
- Tolerance (needing more for the same effect) and dependence.
- Long-term use may make trauma-related symptoms worse over time.
- Veterans with both PTSD and cannabis use disorder had stronger cravings, more withdrawal and higher relapse rates. Cannabis use disorder means use has become hard to control and causes problems.
- In some studies, cannabis use was linked to more people dropping out of trauma-focused therapy. Not every study found this.
The fourth risk matters most, even though the evidence is mixed. It shows how something with no direct effect on PTSD could still do harm. Trauma-focused therapy works, but it is hard. The person must deliberately face the memories they have spent their life avoiding.
Dropping out is the main reason this therapy fails. So anything that makes avoidance easier works directly against the treatment with the best evidence.
What you can do: if you are in trauma-focused therapy and also use cannabis, tell your therapist. They can then watch for avoidance and help you finish the programme, which is where the proven benefit lies.
6. What trauma-focused psychotherapy is
Trauma-focused psychotherapy is a group of talking treatments led by a trained therapist. They work directly on the trauma memory and on what the person has come to believe because of it. Step by step, with support, the brain relearns that the memory is not a danger in the present. This is the fear extinction process described in section 1.
The best-known forms are listed below. The 2023 VA/DoD guideline recommends all three:
- Cognitive processing therapy: working through harmful beliefs formed after the trauma, such as self-blame.
- Prolonged exposure: going back to the memory and to avoided situations, gradually and safely, until the fear fades.
- Eye movement desensitisation and reprocessing (EMDR): recalling the memory while following guided eye movements.
For PTSD, this group of therapies has the strongest evidence of any treatment discussed in this article. Section 9 explains where to start in Thailand.
Translator’s note: Not every Thai hospital has therapists trained in each of these methods. When you book an appointment, ask directly whether trauma-focused therapy is offered. If it is not, ask for a referral to a hospital that offers it.
What you can do: at your first appointment, use the words “trauma-focused therapy”. This helps the clinic send you to the right type of care, not only to medicines for symptoms.
7. Sleep is a separate question
The trial did measure insomnia, with a questionnaire called the Insomnia Severity Index, and found no difference between the groups. Sleep still deserves its own discussion, because many patients do not say their PTSD improved. They say they could sleep.
Poor sleep and nightmares are a core part of PTSD and among its most distressing symptoms. There is separate research on cannabinoids and sleep. Some of it covers nabilone, a lab-made cannabinoid medicine studied specifically for nightmares. That evidence is limited and comes from small studies.
The 2023 VA/DoD guideline does not list nabilone among its recommended treatments for nightmares. The only drug it suggests for nightmares is prazosin, an older blood-pressure medicine. So mentioning nabilone here is not a recommendation.
Cannabis and chronic insomnia has its own article. It covers the part patients like least. Cannabis changes sleep architecture, meaning how a night is split between light sleep, deep sleep and dreaming sleep. The article also explains what happens to sleep when you stop.
“It helps me sleep” and “it treats my PTSD” are different claims. The trial above found no difference from placebo on either one, but it was short and small, and sleep was not its main question.
What you can do: if cannabis seems to help your sleep, keep a short daily diary. Write down your hours of sleep, your nightmares and your other PTSD symptoms on separate lines. The diary shows your doctor which symptom changed. Read the insomnia article before you plan long-term use.
8. What still holds from the older argument
Two parts of the older argument hold up under checking. They should not be thrown out with the rest.
Opioids are the wrong treatment for PTSD. The prescribing pattern found in 2012 was a real failure. The worst part was that 41% of veterans with PTSD who got opioids were also given sedative-hypnotics.
Veterans were not being listened to. Patients asked for something, were refused, and then got it themselves without medical supervision. This pattern appears across all of medical cannabis. It is a real finding about health systems, whether or not the treatment they asked for works.
The jump from these two points to “cannabis is an effective PTSD treatment” does not hold. The only controlled trial so far was small and short, and it found no difference from placebo. Until larger trials report results, the benefit remains unproven.
What you can do: when you discuss this topic, keep the two valid points separate from the claim that cannabis works. You can agree that opioids were overused and patients were ignored without claiming cannabis treats PTSD.
9. In Thailand
Translator’s note: The following Thai rules apply as of this edit.
- Cannabis flower (ช่อดอกกัญชา) is a controlled herb under the Notification of the Ministry of Public Health Re: Controlled Herbs (Cannabis), B.E. 2568. It was issued under the Thai Traditional Medicine Protection Act B.E. 2542 and has been in force since 26 June 2025.
- Flower may be sold only with a PT 33 prescription from an authorised practitioner. Each prescription covers no more than 30 days’ supply.
- Advertising and online sale of cannabis flower are prohibited.
- In 2026 two Ministerial Regulations of B.E. 2569 tightened licensing. The regulation on cannabis or hemp extracts came into force on 26 April 2026. The Controlled Herbs (No. 2) regulation came into force on 30 April 2026 and tightens licence criteria for cannabis flower.
- The Cannabis Control Act is still a draft and not yet law. The Cabinet approved the draft on 22 September 2026 and sent it to the House, so the rules may change.
PTSD is not one of the conditions with supporting evidence. A prescriber considering it would have to weigh an unproven benefit against documented risks. Those risks include dependence and moving away from treatments that work.
Almost all the evidence above comes from US veterans. Nobody has tested it in civilian trauma survivors in Thailand or elsewhere in Southeast Asia. The results may not carry over directly.
Translator’s note for farm and shop operators: Do not present cannabis as a PTSD treatment in posts, on product information or when talking with visitors. Advertising flower is prohibited, and the only controlled trial does not support the claim.
Where to start if trauma symptoms affect your life: trauma-focused psychological therapies have the strongest evidence (section 6). In Thailand, a practical first step is the psychiatry service at a public hospital. You can also call the Department of Mental Health hotline 1323, which can help you with next steps. Of all the advice in this article, this step is the most useful.
Share your experience
If you have PTSD and have used cannabis, you can help fill a gap in the research. Reply below this topic and describe exactly what changed: sleep, nightmares, constant alertness, avoidance or the memories themselves. Please also say whether it changed how you took part in other treatment. The research is missing these details. Please describe your experience only, and do not post where to buy flower.
References
- Seal KH, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307(9):940–947. doi:10.1001/jama.2012.234
- Bonn-Miller MO, et al. The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial. PLOS ONE. 2021;16(3):e0246990. doi:10.1371/journal.pone.0246990
- US Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for the Management of Posttraumatic Stress Disorder and Acute Stress Disorder, 2023. VA.gov | Veterans Affairs (published synopsis: Schnurr et al., Annals of Internal Medicine, 2024; PubMed 38408360)
This article is general information for the Asiannabis community, not medical advice. If you are in distress, contact a health professional or someone you trust today. In Thailand you can also call the Department of Mental Health hotline 1323.